HomeNewsBusinessReal Estate1,500 industries, 100 construction projects can resume work in Noida: CEO Ritu Maheshwari

1,500 industries, 100 construction projects can resume work in Noida: CEO Ritu Maheshwari

So far, 1,800 applications to resume work have been rejected.

May 11, 2020 / 13:41 IST
Story continues below Advertisement

As many as 1,500 industries, which employ around 70,000 people, and 100 construction projects that will need at least 8,000 labourers have been allowed to resume work in Noida. But 1,800 applications have been turned down as they didn’t meet COVID-19 norms, Ritu Maheshwari, the chief executive officer of Noida Authority, tells Moneycontrol’s Vandana Ramnani in an interview.

Edited excerpts:

Story continues below Advertisement

Q) How many industries have been given the go-ahead to resume work?

The process is ongoing and as per the government’s guidelines, we are regularly getting applications and processing them. These include both industries and construction projects. As many as 1,500 industries in the Noida Authority area have been granted permissions to resume work. These employ a workforce of over 70,000. There are around 1,100 industries by Noida Authority (employing 62,000 labourers) and 400 industries through the MSME department.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show